Results 211 to 220 of about 141,956 (266)

Elevated desmoglein‐2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high‐risk cytogenetics and a distinct gene expression profile

British Journal of Haematology, EarlyView.
Barbara J. McClure, John Toubia, Charlotte E. J. Toomes, O. Giles Best, Angelina Yong, Cindy H. Lee, Claudine S. Bonder, Chung Hoow Kok   +7 more
wiley   +1 more source

Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy. [PDF]

Bone Marrow Transplant
Alonso-Saladrigues A, Esperanza-Cebollada E, Vicente-Garcés C, Perez-Jaume S, Sánchez-Sierra N, Richarte-Franqués M, Català A, Crespo-Carrasco A, Dapena JL, Cuatrecasas Capdevila E, Faura Morros A, Ruiz-Cobo MA, Arqués L, Conde Cuevas N, Andreu S, Isola I, Jordan I, García-Rey E, Llanos C, Marsal J, Celis V, Camós M, Torrebadell M, Vega-García N, Rives S.   +24 more
europepmc   +1 more source

Retrospective cohort study on cervicovaginal swabs for the non-invasive molecular detection of ovarian and endometrial cancers. [PDF]

Front Oncol
Han D, Zhang S, Jin Y, Chen X, Yan H, Peng Y.   +5 more
europepmc   +1 more source

Optimizing Precision Oncology: Structural Frameworks for Local MTB Integration and Outcome Assessment. [PDF]

Med Sci (Basel)
Antone NZ, Andreicovici F, Deac AL, Pintican R, Miclaus M, Trifa AP, Catana A, Balacescu O, Vlad C, Achimas-Cadariu P.   +9 more
europepmc   +1 more source

Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front‐line hypomethylating agents and venetoclax: A retrospective Italian study

British Journal of Haematology, EarlyView.
Ilaria Tanasi, Edoardo Tamellini, Elena Marchetti, Eleonora De Bellis, Cristina Ancora, Francesco Angotzi, Davide Facchinelli, Francesca Capraro, Giulia Battaglia, Alessandra Sperotto, Michele Gottardi, Matteo Leoncin, Mauro Krampera, Mario Tiribelli, Carmela Gurrieri   +14 more
wiley   +1 more source

A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma. [PDF]

Int J Biol Sci
Zheng L, Li M, Li X, Wei J, Xue C, Wei Q, Duan Y, Xin H, Wu Z, Zeng T, Xiong W, Fan S, Zhou M, Deng H.   +13 more
europepmc   +1 more source

Real‐world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high‐risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry

British Journal of Haematology, EarlyView.
Kenneth J. C. Lim, Elham Ashrafi, Cameron Wellard, Elizabeth M. Moore, Betty Gration, Bradley Augustson, Peter Mollee, Jennifer Zhang, Nicole Wong Doo, Karen Dun, Rachel Cooke, Sabine Ringkowski, Adam Bryant, Georgia McCaughan, Erica Wood, Zoe McQuilten, P. Joy Ho, Hang Quach, Andrew Spencer   +18 more
wiley   +1 more source

Editorial: p53 in cancer therapy: the impact of mutations on the genome guardian. [PDF]

Front Immunol
Mir MA, Bhat A, Macha MA, Mehraj U, Verma N, Masoodi G.   +5 more
europepmc   +1 more source

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma. [PDF]

Cells
Labrador M, Cozzubbo S, Porro M, Cumerlato M, Bandini C, Mereu E, Paradzik T, Donati B, Manicardi V, Ronchetti D, D'Agostino M, Larocca A, Gay F, Bruno B, Ciarrocchi A, Chatr-Aryamontri A, Neri A, Morelli E, Piva R.   +18 more
europepmc   +1 more source